By Ludwig Burger and Patricia Weiss FRANKFURT, March 10 (Reuters) - BioNTech's two co-founders and leading executives will leave the COVID-19 vaccine maker by the end of the year to start a new ...

By Ludwig Burger FRANKFURT, March 10 (Reuters) - The two co-founders and leading executives of Germany's BioNTech will leave ...

Clinicians must consider patient comorbidities and therapy safety when selecting immunotherapy for cSCC, says Todd ...

Statista, a global data company that publishes insights for 170 industries, projects four cancer therapies will be among the top 10 best-selling pharmaceutical products in the U.S. this year.  The ...

Are time commitments related to cancer care toxic? Depends on who you ask.The term “time toxicity” has become cancer jargon over the past few years, sparking research into how much time patients spend ...

A 45-year-old Indian national has been sentenced to 43 months in prison for conspiring to sell tens of thousands of dollars’ worth of counterfeit cancer medication that he privately compared to “just ...

Wall Street isn't focusing on that risk; it has pushed Eli Lilly's stock price sharply higher. The price-to-earnings (P/E) ...

A 45-year-old Indian national, Sanjay Kumar, was sentenced Thursday to 43 months in federal prison for his role in a ...

A 45-year-old foreign national has been sentenced to federal prison for selling counterfeit oncology pharmaceuticals in the United States, according to U.S. Attorney Nicholas J. Ganjei.

A federal judge in Houston sentenced a man to 43-months in prison and ordered him to pay restitution after he was convicted ...

A Houston federal judge has sent a counterfeit cancer drug seller to prison for nearly four years after investigators discovered vials labeled as Keytruda that contained no real cancer-fighting ...

A 45-year-old man has been sentenced to prison for his role in selling tens of thousands of dollars' worth of counterfeit ...